- Home
- CTNT vs APRE Comparison
CTNT vs APRE Comparison
Compare CTNT & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- APRE
- Stock Information
- Founded
- CTNT 2016
- APRE 2006
- Country
- CTNT United States
- APRE United States
- Employees
- CTNT N/A
- APRE N/A
- Industry
- CTNT
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTNT
- APRE Health Care
- Exchange
- CTNT Nasdaq
- APRE Nasdaq
- Market Cap
- CTNT 6.1M
- APRE 6.9M
- IPO Year
- CTNT 2023
- APRE 2019
- Fundamental
- Price
- CTNT $1.29
- APRE $1.18
- Analyst Decision
- CTNT
- APRE Strong Buy
- Analyst Count
- CTNT 0
- APRE 1
- Target Price
- CTNT N/A
- APRE $20.00
- AVG Volume (30 Days)
- CTNT 326.7K
- APRE 148.6K
- Earning Date
- CTNT 11-07-2025
- APRE 11-12-2025
- Dividend Yield
- CTNT N/A
- APRE N/A
- EPS Growth
- CTNT N/A
- APRE N/A
- EPS
- CTNT N/A
- APRE N/A
- Revenue
- CTNT $1,420,060.00
- APRE $488,239.00
- Revenue This Year
- CTNT $302.80
- APRE N/A
- Revenue Next Year
- CTNT $22.22
- APRE N/A
- P/E Ratio
- CTNT N/A
- APRE N/A
- Revenue Growth
- CTNT N/A
- APRE N/A
- 52 Week Low
- CTNT $1.12
- APRE $1.15
- 52 Week High
- CTNT $8.50
- APRE $5.00
- Technical
- Relative Strength Index (RSI)
- CTNT 32.80
- APRE 36.10
- Support Level
- CTNT $1.20
- APRE $1.21
- Resistance Level
- CTNT $1.40
- APRE $1.32
- Average True Range (ATR)
- CTNT 0.09
- APRE 0.07
- MACD
- CTNT -0.02
- APRE -0.02
- Stochastic Oscillator
- CTNT 20.30
- APRE 16.96
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.